The Big Idea

Supporting the Pharmaceutical and Healthcare Industry

The pharmaceutical industry in US is a steadily growing and largest in the world in terms of sales and prescriptions dispensed. The prescription drug market is slated to reach US$600 Billion by 2023. Navigating through this industry is a daunting challenge and it is of vital importance to have the support and guidance in understanding the ever-changing dynamics of this industry.

Undertaking and executing multiple strategies and innovative ideas needed to leverage this massive, growing and diverse market-place to carve out a niche’ is what ARAI Consulting Services supports. Leveraging our massive global network of healthcare companies, organizations and executives, we strategize and implement plans which support your growth goals.

ANAND RAI

Advisor, Consultant, Executive, Pharmacist

Pharm, Master's in Pharmaceutical Marketing
Business Development, Commercialization Strategies and Execution, Portfolio and Pipeline Management, Alliance Management

Broad and extensive experience in all aspects of commercial strategy, marketing, finance, product development and alliance management.

Utilizing a unique blend of technical, strategic, business, legal, operations, financial and interpersonal skills to leverage various aspects of the pharmaceutical and healthcare arena to drive growth and success.

Proven ability to identify, analyze and lead business opportunities and negotiate various forms of complex agreements to execute business strategies.

Professional Experience and Expertise

PACK Pharmaceuticals LLC (2006-2014): Core Founding Team Member

• Manage portfolio and pipeline products for the company, performing detailed market research and analysis, including technical insight.

• Critical role in Business Development and Alliance Management en-route to creating a network of 25 development and manufacturing partners worldwide.

• Strategize and execute on commercial opportunities including new products, marketing plans and strategies for branded and generic products.

• Pivotal role in Sales, Marketing, Operations and R&D.

• Part of Founding Core Group and Strategic Think Tank, building the company from ground up, eventually divesting to Aceto Corporation for $100 Million.

Integration and Continuation of Business – ACETO Corp and Rising Pharmaceuticals LLC (2014-2016)

• Manage the overall integration process of PACK Pharmaceuticals and Rising Pharmaceuticals under ACETO corporation.

• Strategic involvement in the commercial business, portfolio and pipeline management and business development including but not limited to accommodating the transition of partnerships to Rising Pharmaceuticals under ACETO. Streamline the operational processes while maintaining alliances and growing the business.

• Establish the strategy and lead process on barrier-based initiatives within the portfolio development and management, including ideas relevant to dosage form, technology and market size.

• Create a partner optimization strategy that best utilizes existing partner relationship and identify gaps in capabilities for business development resolution.

• Development and implementation of institutional strategy including but not limited to Injectables/Parenteral for the company from ground up

CAMERON Pharmaceuticals LLC (2016-2020): Founding Team Member and Equity Holder

• Equity partner responsible for the growth of the business, including Business Development, Pipeline and Portfolio Management and R&D.

• Strategy and portfolio management based on current market scenarios. Identification of new product, therapeutic areas and business opportunities, creation of optimal business plans and execution of such business plans.

• Partner optimization strategies including market assessments, identification of business development gaps and resolutions of the same.

• Build, negotiate and execute deals that best fit with corporate goals. Development of global market strategies.

• Oversee sales, marketing, regulatory, quality, finance, legal and various internal operations.

• Part of successful launches of multiple in-licensed or owned products to grow the current portfolio and pipeline.

• Responsible for growth of the company from ground up, and successfully get the company to $90 million in Gross Sales

Report abuse